Thursday, November 29, 2012

Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data.

Is bypass surgery better than medical therapy for patients with stable ischemic heart disease? What about patients with triple vessel disease? This landmark study found that the mortality rate was no different in those undergoing bypass surgery compared to those undergoing medical therapy, even those with triple vessel disease.

Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data.